American Cannabis Company, Inc. - Quarter Report: 2015 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2015.
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______.
Commission File Number 000-26108
AMERICAN CANNABIS COMPANY, INC.
(Exact name of registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
94-2901715 (I.R.S. Employer Identification No.) | ||
3457 Ringsby Court, Unit
111 |
80216 |
(720) 466-3789
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ] | Accelerated filer [ ] | Non-accelerated filer [ ] | Smaller reporting company [X] | |||
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]
On May 6, 2015, 44,593,750 shares of common stock were outstanding.
PART I. FINANCIAL INFORMATION | Page | |
Item 1. | FINANCIAL STATEMENTS (Unaudited): |
3 |
CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MARCH 31, 2015 AND DECEMBER 31, 2014 | 3 | |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2015 AND THE THREE MONTHS ENDED MARCH 31, 2014 |
4 | |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2015 AND MARCH 31, |
5 | |
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS | 6 | |
Item 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
11 |
Item 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 14 |
Item 4. | CONTROLS AND PROCEDURES | 14 |
PART II. OTHER INFORMATION | ||
Item 1. | LEGAL PROCEEDINGS | 16 |
Item 1A. | RISK FACTORS | 16 |
Item 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 16 |
Item 3. | DEFAULTS UPON SENIOR SECURITIES | 16 |
Item 5. | OTHER INFORMATION | 16 |
Item 6. | EXHIBITS | 16 |
Signatures | 16 |
PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
AMERICAN CANNABIS COMPANY, INC. AND SUBSIDIARY
FORMERLY BRAZIL INTERACTIVE MEDIA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
March 31, 2015 | December 31, 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 316,771 | $ | 165,213 | ||||
Accounts receivable, net | 106,185 | 57,642 | ||||||
Deposits | 65,013 | 181,941 | ||||||
Inventory | 150,780 | 4,555 | ||||||
Prepaid expenses and other current assets | 143,829 | 12,325 | ||||||
Total current assets | 782,578 | 421,676 | ||||||
Property and equipment, net | 58,950 | 48,416 | ||||||
Total assets | $ | 841,528 | $ | 470,092 | ||||
Liabilities and stockholders' equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 243,957 | $ | 62,136 | ||||
Deferred revenue | 25,000 | 173,528 | ||||||
Convertible note, net of discount | 33,354 | 24,551 | ||||||
Accrued and other current liabilities | 198,040 | 52,747 | ||||||
Total current liabilities | 500,351 | 312,962 | ||||||
Total liabilities | 500,351 | 312,962 | ||||||
Commitments and contingencies (Note 12) | ||||||||
Stockholders' equity | ||||||||
Preferred stock; $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding | — | — | ||||||
Common stock, $0.00001 par value; 100,000,000 shares authorized; 44,593,750 and 44,518,750 issued and outstanding at March 31, 2015 and December 31, 2014, respectively | 446 | 446 | ||||||
Additional paid-in capital | 4,183,182 | 3,699,526 | ||||||
Retained deficit | (3,842,451 | ) | (3,542,842 | ) | ||||
Total stockholders' equity | 341,177 | 157,130 | ||||||
Total liabilities and stockholders' equity | $ | 841,528 | $ | 470,092 |
The accompanying notes are an integral part of these consolidated unaudited financial statements
AMERICAN CANNABIS COMPANY, INC. AND SUBSIDIARY
FORMERLY BRAZIL INTERACTIVE MEDIA,
INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three Months | Three Months | |||||||
Ended | Ended | |||||||
March 31, 2015 | March 31, 2014 | |||||||
Revenues | ||||||||
Consulting services | $ | 195,570 | $ | 23,864 | ||||
Products and equipment | 248,097 | 7,448 | ||||||
Total revenues | 443,667 | 31,312 | ||||||
Costs of revenues | ||||||||
Cost of consulting services | 100,892 | 19,425 | ||||||
Cost of products and equipment | 225,651 | 7,025 | ||||||
Total cost of revenues | 326,543 | 26,450 | ||||||
Gross Profit | 117,124 | 4,862 | ||||||
Operating expenses | ||||||||
General and administrative | 210,499 | 18,006 | ||||||
Selling and marketing | 94,305 | 21,445 | ||||||
Research and development | 30,372 | — | ||||||
Total operating expenses | 335,176 | 39,451 | ||||||
Income (loss) from operations | (218,052 | ) | (34,589 | ) | ||||
Other income (expense) | ||||||||
Interest income (expense), net | (8,786 | ) | (43 | ) | ||||
Total other income (expense) | (8,786 | ) | (43 | ) | ||||
Net income (loss) before income taxes | (226,838 | ) | (34,632 | ) | ||||
Income tax expense (benefit) | — | — | ||||||
Net income (loss) | $ | (226,838 | ) | $ | (34,632 | ) | ||
Basic and diluted net income (loss) per common share | $ | (0.01 | ) | $ | (0.00 | )* | ||
Basic and diluted weighted average common shares outstanding | 44,782,078 | 25,368,502 | ||||||
*denotes net loss per common share of less than $0.01. |
The accompanying notes are an integral part of these consolidated unaudited financial statements
AMERICAN CANNABIS COMPANY, INC. AND SUBSIDIARY
FORMERLY
BRAZIL INTERACTIVE MEDIA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months | Three Months | |||||||
Ended | Ended | |||||||
March 31, 2015 | March 31, 2014 | |||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | (226,838 | ) | $ | (34,632 | ) | ||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||||
Depreciation | 716 | 147 | ||||||
Amortization of discount on convertible notes payable | 8,803 | — | ||||||
Stock-based compensation to employees | 43,271 | — | ||||||
Stock-based compensation to service providers | 63,841 | — | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (48,542 | ) | 1,250 | |||||
Deposits | 116,929 | (27,000 | ) | |||||
Inventory | (146,225 | ) | — | |||||
Prepaid expenses and other current assets | (4,957 | ) | 3,118 | |||||
Deferred revenue | (148,528 | ) | 3,516 | |||||
Accrued and other current liabilities | 72,312 | 17,862 | ||||||
Accounts payable | 182,026 | 3,377 | ||||||
Net cash used in operating activities | (87,192 | ) | (32,362 | ) | ||||
Cash flows from investing activities: | ||||||||
Purchases of property and equipment | (11,250 | ) | — | |||||
Net cash used in investing activities | (11,250 | ) | — | |||||
Cash flows from financing activities: | ||||||||
Proceeds from sale of common stock | 250,000 | — | ||||||
Proceeds from short-term notes payable | — | 35,000 | ||||||
Distributions to stockholders | — | (4,000 | ) | |||||
Net cash provided by financing activities | 250,000 | 31,000 | ||||||
Net increase (decrease) in cash and cash equivalents | 151,558 | (1,362 | ) | |||||
Cash and cash equivalents at beginning of period | 165,213 | 17,597 | ||||||
Cash and cash equivalents at end of period | 316,771 | 16,235 | ||||||
Supplemental disclosure of cash flow information: | ||||||||
Cash paid for (received from) interest | $ | (17 | ) | $ | 43 | |||
Cash paid for (received from) income taxes, net | $ | — | $ | — |
The accompanying notes are an integral part of these consolidated unaudited financial statements
AMERICAN CANNABIS COMPANY, INC. AND SUBSIDIARY
FORMERLY
BRAZIL INTERACTIVE MEDIA, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE MONTHS ENDED MARCH 31, 2015 AND 2014
(Unaudited)
Note 1. Description of the Business
American Cannabis Company, Inc. and its subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, designs industry-specific products and facilities, and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.
American Cannabis Company, Inc. was incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.
On March 13, 2013, Naturewell, Inc. completed a merger transaction whereby it acquired 100% of the issued and outstanding share capital of Brazil Interactive Media, Inc. (“BIMI”), which operated as a Brazilian interactive television company and television production company through its wholly owned Brazilian subsidiary company EsoTV Brasil Promoção Publicidade Licenciamento e Comércio Ltda. (“EsoTV”). Naturewell’s Articles of Incorporation were amended to reflect a new name: Brazil Interactive Media, Inc.
On May 15, 2014, BIMI entered into a merger agreement (“the Merger Agreement”) to acquire 100% of the issued and outstanding American Cannabis Consulting while simultaneously disposing of 100% of the issued share capital EsoTV (“the Separation Agreement”). Both the merger with American Cannabis Consulting and disposal of EsoTV were completed on September 29, 2014. BIMI subsequently amended its Articles of Incorporation to change its name to American Cannabis Company, Inc.. On October 10, 2014, American Cannabis Company, Inc changed its stock symbol from BIMI to AMMJ.
The foregoing descriptions of the Merger Agreement and Separation Agreement do not purport to be complete and are qualified in their entirety by the terms of such agreements, which are filed as exhibits to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on October 3, 2014.
Immediately following the completion of the Merger Agreement, former shareholders of American Cannabis Consulting owned 31,710,628 shares of American Cannabis Company, Inc.’s common stock representing 78.44% of American Cannabis Company, Inc.’s issued and outstanding share capital. Accordingly, American Cannabis Consulting was deemed to have been the accounting acquirer in a Reverse Merger which resulted in a recapitalization of the Company. Consequently, the Company’s condensed consolidated financial statements reflect the results of American Cannabis Consulting since Inception (March 5, 2013) and of American Cannabis Company, Inc. (formerly BIMI) since September 29, 2014.
Note 2. Summary of Significant Accounting Policies
Basis of Accounting
The financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company has elected a fiscal year ending on December 31. Certain balance sheet reclassifications have been made to prior period balances to reflect the current period’s presentation format; such reclassifications had no impact on the Company’s consolidated statements of operations or consolidated statements of cash flows and had no material impact on the Company’s consolidated balance sheets.
Use of Estimates in Financial Reporting
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the financial statements in the period they are deemed to be necessary. Significant estimates made in the accompanying financial statements include but are not limited to following: those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, contingencies and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements.
Unaudited Interim Financial Statements
The accompanying unaudited financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.
Cash and Cash Equivalents
The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.
Accounts Receivable
Accounts receivable are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.
The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. The Company’s allowance for doubtful accounts was $4,497 and $9,338 as of March 31, 2015 and December 31, 2014, respectively. The Company did not record bad debt expense during the three months ended March 31, 2015 or during the three months ended March 31, 2014.
Deposits
Deposits is comprised of advance payments made to third parties, primarily for inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below).
Inventory
Inventory is comprised of products and equipment owned by the Company to be sold to end-customers. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of March 31, 2015 and December 31, 2014, market values of all of the Company’s inventory were greater than cost, and accordingly, no such valuation allowances were recognized.
Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.
Significant Clients and Customers
For the three months ended March 31, 2015, two customers individually accounted for 10% or more of the Company’s revenues; these customers accounted for approximately 66% of the Company’s total revenues for the period. For the three months ended March 31, 2014, three clients individually accounted for 10% or more of the Company’s revenues, and in aggregate, they comprised approximately 82% of the Company’s total revenues for the period.
As of March 31, 2015, three customers accounted for 10% or more of the Company’s accounts receivable balance; these customers accounted for approximately 79% of the Company’s accounts receivable balance at that date. As of December 31, 2014, three customers accounted for 10% or more of the Company’s accounts receivable balance; these customers accounted for approximately 88% of the Company’s gross accounts receivable balance at that date.
Property and Equipment, net
Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred and depreciation is consummated once the underlying asset is placed into service. Property and equipment is reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of March 31, 2015 or December 31, 2014.
Accounting for the Impairment of Long-Lived Assets
The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of March 31, 2015 or December 31, 2014.
Beneficial Conversion Feature
If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). A BCF is recorded by the Company as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt using the effective interest method.
Revenue Recognition
Revenue is recognized in accordance with FASB ASC Topic 605, Revenue Recognition. The Company recognizes revenue when persuasive evidence of an arrangement exists, the related services are rendered or delivery has occurred, the price is fixed or determinable and collectability is reasonably assured.
The Company generates revenues from professional services consulting agreements. These arrangements are generally entered into on a time basis, for a fixed-fee or on a contingent fee basis. Generally, a prepayment or retainer is required prior to performing services.
Revenues from time-based engagements are recognized as the hours are incurred by the Company.
Revenues from fixed-fee engagements are recognized under the completed or proportional performance methods. Management reviews arrangement to determine whether or not the fixed-fee is for a final deliverable or act which is significant to the arrangement as a whole. If it is, revenue is recognized under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered. Revenue recognized under the proportional performance method is recognized as services are performed. Under this method, the Company estimates the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable in order to determine the amount of revenue to be recognized. Revenue recognition is affected by a number of factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. During the three month periods ended March 31, 2015 and March 31, 2014, no such losses have occurred. The Company believes if an engagement terminates prior to completion it can recover the costs incurred related to the services provided.
The Company has some arrangements for which revenues are contingent upon achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.
The Company’s arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”). Revenues are recognized in accordance with our accounting policies for the elements as described above. The elements qualify for separation when the deliverables have value on a stand-alone basis and the value of the separate elements can be established by VSOE or an estimated selling price. While assigning values and identifying separate elements requires judgment, generally selling prices of the separate elements are readily identifiable as the Company also sells those elements individually outside of a multiple services engagement. Contracts with multiple elements are typically fixed-fee or on time basis. Arrangements are typically terminable by either party upon sufficient notice and do not include provisions for refunds relating to services provided.
Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenue in the accompanying balance sheet. Revenues recognized for services performed, but not yet billed to clients are recorded as unbilled services.
Reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses are included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are presented in the statement of operations on a net basis.
Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained, the price is fixed and determinable, the product is shipped, title has transferred and collectability is reasonably assured. Generally, our suppliers’ drop-ship orders to our clients with origin terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. During the three months ended March 31, 2015 and March 31, 2014, sales returns were not significant and as such, no sales return allowance had been recorded as of March 31, 2015 and December 31, 2014.
Costs of Revenues
The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.
Advertising and Promotion Costs
Advertising and promotion costs are included as a component of selling and marketing expense and are expensed as incurred. During the three months ended March 31, 2015 and March 31, 2014, these costs were $275 and $70, respectively.
Shipping and Handling Costs
For product and equipment sales, shipping and handling costs are included as a component of cost of revenues.
Stock-Based Compensation
Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. The Company recognizes related compensation costs on a straight-line basis over the requisite vesting period of the award. During the three months ended March 31, 2015, stock-based compensation expense for restricted shares was $43,271. Compensation expense for warrants and options is based on the fair value of the instruments on the grant date, which is determined using the Black-Scholes valuation model. During the three months ended March 31, 2015, there was no compensation expense for warrants or stock options. Compensation expense for common shares of stock is based on an assessment of fair value as of the grant date and is recognized over the vesting period, or if the common shares immediately vest, is recognized in full upon the grant. There were no grants of any kind during or outstanding for the three months ended March 31, 2014, and accordingly, no stock-based compensation costs for the period.
Income Taxes
The Company’s corporate status changed from an S-Corporation, which it had been since inception, to a C-Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S-Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S-Corporation’s taxable income. Accordingly, we were not subject to income taxes for the three months ended March 31, 2014. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the three months ended March 31, 2015, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of March 31, 2015 and December 31, 2014, we had no liabilities related to federal or state income taxes and the carrying value of our deferred tax asset was zero.
Net Income (Loss) Per Common Share
The Company reports net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.
Related Party Transactions
The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.
Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.
The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which statements of operation are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which statements of operations are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
See Note 11. Related Party Transactions for associated disclosures.
Recent Accounting Pronouncements
The Company has reviewed all the recently issued, but not yet effective, accounting pronouncements and it does not believe any of these pronouncements will have a material impact on the Company.
Note 3. Accounts Receivable, net
Accounts receivable, net, was comprised of the following as of March 31, 2015 and December 31, 2014:
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Gross accounts receivable | $ | 110,682 | $ | 66,980 | ||||
Less: allowance for doubtful accounts | (4,497 | ) | (9,338 | ) | ||||
Accounts receivable, net | $ | 106,185 | $ | 57,642 |
The Company had no bad debt expense during the three months ended March 31, 2015 and March 31, 2014.
Note 4. Deposits
Deposits was comprised of the following as of March 31, 2015 and December 31, 2014:
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Inventory deposits | $ | 63,013 | $ | 179,941 | ||||
Operating lease deposits | 2,000 | 2,000 | ||||||
Deposits | $ | 65,013 | $ | 181,941 |
Inventory deposits reflect down payments made to suppliers or manufacturers under inventory purchase agreements.
Note 5. Inventory
Inventory as of March 31, 2015 and December 31, 2014 of $150,780 and $4,555, respectively, was fully comprised of finished goods.
Note 6. Prepaid expenses and other current assets
Prepaid expenses and other current assets was comprised of the following as of March 31, 2015 and December 31, 2014:
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Prepaid professional services to be compensated in stock | $ | 126,347 | $ | — | ||||
Prepaid expenses | 14,273 | 9,454 | ||||||
Other current assets | 3,209 | 2,871 | ||||||
Prepaid expenses and other current assets | $ | 143,829 | $ | 12,325 |
Note 7. Property and Equipment, net
Property and equipment, net, was comprised of the following as of March 31, 2015 and December 31, 2014:
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Office equipment | $ | 5,742 | $ | 5,742 | ||||
Furniture and fixtures | 2,935 | 2,935 | ||||||
Machinery and equipment | 1,250 | 1,250 | ||||||
Construction in progress | 51,301 | 40,051 | ||||||
Property and equipment, gross | 61,228 | 49,978 | ||||||
Less: accumulated depreciation | (2,278 | ) | (1,562 | ) | ||||
Property and equipment, net | $ | 58,950 | $ | 48,416 |
The Company recorded depreciation expense of $716 and $147 during the three months ended March 31, 2015 and March 31, 2014, respectively. During the three months ended March 31, 2015, the Company capitalized $11,250 of additional expenses associated with its demonstration inventory unit.
Note 8. Notes Payable
As of March 31, 2015, the Company had remaining convertible debentures in the total amount of $71,500. The debentures were originally issued on April 24, 2014, mature on April 24, 2016, pay zero interest, and are convertible until maturity at the holders’ discretion into shares of the Company’s common stock at $0.08 per share. The debentures have been discounted in the amount of $71,500 due to the intrinsic value of the beneficial conversion option. As of March 31, 2015, the aggregate carrying value of the debentures was $33,354, net of debt discounts of $38,146, and is reflected on the Company’s consolidated balance sheet as Convertible notes payable, net. Amortization of debt discount, which is reflected on the consolidated statement of operations as interest expense, was $8,803 for the three months ended March 31, 2015.
As of March 31, 2014, the Company had a short-term note payable with a principal amount of $35,000 and an interest rate of 5% per annum that it entered into on March 21, 2014. On May 15, 2014, as a result of the issuance of the convertible notes payable described above, the note was fully satisfied. The Company recorded interest expense related to this note of $43 during the three months ended March 31, 2014. In connection with the Reverse Merger and the issuance of convertible notes payable as described in the preceding paragraph, this short-term note payable was deemed to be fully satisfied. Accordingly, the Company recorded a $35,000 gain on debt extinguishment during the second quarter of 2014.
Note 9. Accrued and Other Current Liabilities
Accrued and other current liabilities was comprised of the following at March 31, 2015 and December 31, 2014:
March 31, | December 31, | |||||||
2015 | 2014 | |||||||
(Unaudited) | (Audited) | |||||||
Accrued legal fees | $ | 108,829 | $ | 101,509 | ||||
Unbilled inventory | 46,550 | — | ||||||
Accrued payroll liabilities | 20,807 | 11,522 | ||||||
Accrued accounting fees | 11,694 | 5,000 | ||||||
Due to directors | 1,999 | 1,999 | ||||||
Other | 8,161 | 5,488 | ||||||
Accrued and other current liabilities | $ | 198,040 | $ | 125,518 |
Note 10. Net Income (Loss) Per Common Share
The following is a reconciliation of weighted common shares outstanding used in the calculation of basic and diluted net income (loss) per common share:
Three Months | Three Months | |||||||
Ended | Ended | |||||||
March 31, 2015 (Unaudited) | March 31, 2014 (Unaudited) | |||||||
Net income (loss) | $ | (226,838 | ) | $ | (34,632 | ) | ||
Weighted average shares used for basic net income (loss) per common share | 44,782,078 | 25,368,502 | ||||||
Incremental diluted shares | — | — | ||||||
Weighted average shares used for diluted net income (loss) per commo share | 44,782,078 | 25,368,502 | ||||||
Net income (loss) per common share: | ||||||||
Basic | $ | (0.01 | ) | $ | (0.00 | )* | ||
Diluted | $ | (0.01 | ) | $ | (0.00 | )* | ||
*denotes net loss of less than $0.01 per common share. |
For the three months ended March 31, 2015, as a result of the net loss for the period, the Company excluded 1,319,774 shares from its calculation of diluted net income (loss) per common share because their effect would have been antidilutive. These shares were comprised of 156,937 shares of restricted stock, 269,087 of warrants and 893,750 of share equivalents associated with convertible notes payable. No potentially dilutive shares were issued or outstanding during the three months ended March 31, 2014.
Note 11. Related Party Transactions
From time to time, the Company purchases inventory and equipment from Baroud Development Group, in which Anthony Baroud, the Company’s Chief Technology Officer, is an owner. During the three months ended March 31, 2015 and March 31, 2014, total such purchases were zero and $27,000, respectively.
During the three months ended March 31, 2014, prior to the Reverse Merger, the Company distributed a total of $4,000 to its co-founders and owners, Corey Hollister and Ellis Smith.
During the three months ended March 31, 2015, the Company incurred $13,887 of expense payable to New Era CPAs, an accounting firm in which Antonio Migliarese, the Company’s Chief Financial Officer, is a partner. This expense is payable in 35,607 shares of the Company’s common stock. As of March 31, 2015, the Company owed Mr. Migliarese $5,000 in cash and 65,607 shares of common stock valued at $32,187.
Note 12. Commitments and Contingent Liabilities
Under the terms of the Company’s agreement with the manufacturer of its exit packing product, the SatchelTM, the Company is committed to the purchase of a total of 500,000 units at a price per unit of $1.00. As of March 31, 2015, a total of 144,600 units had yet to be received, for a remaining purchase commitment of $144,600. As of the date of this report, the manufacturer has not met the delivery schedule established under the agreement, which represents a material breach of the agreement under its terms.
During the three months ended March 31, 2015, the Company entered into an agreement with a third-party service provider for services to be compensated in shares of common stock. Under the terms of the agreement, the Company is obligated to issue 50,000 shares of its common stock upon execution and an additional 150,000 share of its common stock upon the fulfillment of certain stated deliverables.
Under the terms of the Company’s various consulting agreements with clients, the Company is obligated to perform certain future services. The Company is not currently a party to any pending legal proceedings.
Note 13. Stock-based Compensation
During the year ended December 31, 2014, the Company recorded a total of $43,271 of stock-based compensation expense to employees, which was the result of the following activity:
Restricted Shares
From time to time, the Company grants certain employees restricted shares of its common stock to provide further compensation in-lieu of wages and to align the employee’s interests with the interests of its stockholders. Because vesting is based on continued employment, these equity-based incentives are also intended to attract, retain and motivate personnel upon whose judgment, initiative and effort the Company’s success is largely dependent. There were 202,500 restricted shares granted as of March 31, 2015. The fair value of restricted stock units is determined based on the quoted closing price of the Company’s common stock on the date of grant.
The following table summarizes the Company’s restricted share award activity during the three months ended March 31, 2015:
Weighted Average | ||||||||||
Restricted Shares | Grant Date | |||||||||
Common Stock | Fair Value | |||||||||
Outstanding unvested at December 31, 2014 | 150,000 | $ | 0.94 | |||||||
Granted | 52,500 | 0.70 | ||||||||
Vested restricted shares | — | — | ||||||||
Forfeited | — | — | ||||||||
Outstanding unvested at March 31, 2015 | 202,500 | $ | 0.88 |
During the three months ended March 31, 2015, the Company granted 52,500 restricted shares. Total stock-based compensation expense for restricted shares was $43,271 for the three months ended March 31, 2015. The Company had no stock-based compensation activity during or preceding the three months ended March 31, 2014 and no awards outstanding as of March 31, 2014.
Unrecognized stock-based compensation expense related to outstanding unvested restricted shares as of March 31, 2015 is expected to be recognized over a weighted average period of 0.4 years, as follows:
Future Stock-Based | ||||||
Compensation Expense | ||||||
(Restricted Shares) | ||||||
2015 | $ | 136,515 | ||||
2016 | 632 | |||||
Thereafter | — | |||||
Total | $ | 137,147 |
Warrants
As of March 31, 2015, fully-vested warrants issued to the Company’s independent board member to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share were outstanding, exercisable within five (5) years of the date of issuance on November 19, 2014. The grant date fair value of the warrants, as calculated based on the Black-Scholes valuation model, was $0.59 per share. There were no outstanding unvested warrants or new issuances of warrants during the three months ended March 31, 2015; consequently, no stock-based compensation expense associated with warrant was recorded during the three months ended March 31, 2015.
As of March 31, 2015 and December 31, 2014, as the exercise price per share exceeded the price per share of our common shares, there was no aggregate intrinsic value of outstanding warrants. As of March 31, 2015 and December 31, 2014, the warrants had 4.6 and 4.9 years remaining until expiration, respectively. No warrants were issued or outstanding during or preceding the three months ended March 31, 2014.
Stock Options
In addition to the warrants as described above, the Company’s independent board member shall be eligible to receive options for 400,000 shares of common stock under the Company’s incentive plan, as and when duly approved by the Board of Directors. As these stock options were not granted as of March 31, 2015, no expense in relation to these options was recognized during the three months ended March 31, 2015.
Stock Issuable in Compensation for Professional Services
From time to time, the Company enters into agreements whereby a professional service provider will be compensated for services rendered to the Company by shares of common stock in lieu of cash. During the three months ended March 31, 2015, the following related activity occurred:
• | The Company incurred $13,887 of expense payable in 35,607 common shares to New Era CPAs, an accounting firm in which Antonio Migliarese, the Company’s Chief Financial Officer, is a partner. During the year ended December 31 2014, the Company incurred $18,300 of expense payable in 30,000 common shares to New Era CPAs. As of March 31, 2015, as a result of these transactions, 65,607 common shares were earned and issuable to New Era CPAs. |
• | The Company issued 200,000 common shares valued at $156,000 to a professional service provider in exchange for $200 and services to be rendered from January 2015 to January 2016. The Company recorded expense of $29,453 on its condensed consolidated statement of operations during the three months ended March 31, 2015; $126,347 was reflected as prepaid and other current assets as of March 31, 2015. |
• | The Company agreed to issue 200,000 common shares valued at $82,000 to a professional service provider in exchange for services. Of these shares, 50,000 were earned and issuable as of March 31, 2015, for which $20,500 of expense was recognized on the condensed consolidated statement of operations for the period. An additional 150,000 common shares, valued at $61,500, are issuable upon the service provider meeting certain established deliverables. The agreement is effective through August 30, 2015. |
Note 14. Stockholders’ Equity
Preferred Stock
American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding during the three month periods ended March 31, 2015 and March 31, 2014.
Common Stock
American Cannabis Company, Inc. is authorized to issue 100,000,000 common shares at $0.00001 par value per share.
During the three months ended March 31, 2015:
• | Stock-based compensation associated with 202,500 cumulative outstanding restricted shares granted to employees resulted in an increase to additional paid-in capital of $43,271. Of these shares, 52,500 were issued during the three months ended March 31, 2015. |
• | 200,000 shares of common stock, valued at $156,000, were issued as prepaid compensation for professional services settled in stock in lieu of cash. As of March 31, 2015, $29,453 of this expense was recognized and $126,347 was reflected on the consolidated balance sheet within prepaid expenses and other current assets. |
• | 125,000 shares of previously issued common stock were rescinded and canceled. |
Common Stock Shares Issuable
During the three months ended March 31, 2015:
• | The Company sold 833,333 shares of common stock for $250,000 of cash; these shares were fully issuable as of March 31, 2015, |
• | 50,000 shares of common stock, valued at $20,500, were earned and issuable as compensation for professional services settled in stock in lieu of cash, and |
• | 35,607 shares of common stock, valued at $13,887, were earned by and issuable to an accounting firm in which the Company’s Chief Financial Officer is a partner as compensation for professional services to be settled in stock in lieu of cash. |
As a result of the transactions described above, as of March 31, 2015, there were 44,593,750 shares of our common stock issued and outstanding and the balances of common stock and additional paid-in capital were $446 and $4,183,182, respectively. An additional 948,940 shares of common stock were issuable to an investor and various service providers.
Note 15. Reportable Segments
The Company operates in one segment, in the regulated cannabis industry, as a provider of professional consulting services, products and equipment.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate these estimates, including those related to useful lives of real estate assets, cost reimbursement income, bad debts, impairment, net lease intangibles, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.
Background
American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and manage a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. We are a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.
We were incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.
On March 13, 2013, Naturewell, Inc. completed a merger transaction whereby it acquired 100% of the issued and outstanding share capital of Brazil Interactive Media, Inc. (“BIMI”), which operated as a Brazilian interactive television company and television production company through its wholly owned Brazilian subsidiary company, EsoTV Brasil Promoção Publicidade Licenciamento e Comércio Ltda. (“EsoTV”). Naturewell’s Articles of Incorporation were amended to reflect a new name: Brazil Interactive Media, Inc.
On May 15, 2014, BIMI entered into a merger agreement (“the Merger Agreement”) to acquire 100% of the issued and outstanding American Cannabis Consulting while simultaneously disposing of 100% of the issued share capital EsoTV (“the Separation Agreement”). Both the merger with American Cannabis Consulting and disposal of EsoTV were completed on September 29, 2014. BIMI subsequently amended its Articles of Incorporation to change its name to American Cannabis Company, Inc.. On October 10, 2014, American Cannabis Company, Inc changed its stock symbol from BIMI to AMMJ.
The foregoing descriptions of the Merger Agreement and Separation Agreement do not purport to be complete and are qualified in their entirety by the terms of such agreements, which are filed as exhibits to the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) on October 3, 2014.
Immediately following the completion of the Merger Agreement, former shareholders of American Cannabis Consulting owned 31,710,628 shares of American Cannabis Company, Inc.’s common stock representing 78.4% of American Cannabis Company, Inc.’s issued and outstanding share capital. Accordingly, American Cannabis Consulting was deemed to have been the accounting acquirer in a Reverse Merger which resulted in a recapitalization of the Company. Consequently, the Company’s consolidated financial statements reflect the results of American Cannabis Consulting since Inception (March 5, 2013) and of American Cannabis Company, Inc. (formerly BIMI) since September 29, 2014.
Results of Operations
Three months ended March 31, 2015 compared to three months ended March 31, 2014
The following table presents our consolidated operating results for the three months ended March 31, 2015 compared to the three months ended March 31, 2014:
Three Months | Three Months | |||||||||||||||||||
Ended | % of | Ended | % of | |||||||||||||||||
March 31, 2015 | Revenues | March 31, 2014 | Revenues | $ Change | ||||||||||||||||
Revenues | ||||||||||||||||||||
Consulting services | $ | 195,570 | 44.1 | $ | 23,864 | 76.2 | $ | 171,706 | ||||||||||||
Products and equipment | 248,097 | 55.9 | 7,448 | 23.8 | 240,649 | |||||||||||||||
Total revenues | 443,667 | 100.0 | 31,312 | 100.0 | 412,355 | |||||||||||||||
Costs of revenues | ||||||||||||||||||||
Cost of consulting services | 100,892 | 22.7 | 19,425 | 62.0 | 81,467 | |||||||||||||||
Cost of products and equipment | 225,651 | 50.9 | 7,025 | 22.4 | 218,626 | |||||||||||||||
Total cost of revenues | 326,543 | 73.6 | 26,450 | 84.5 | 300,093 | |||||||||||||||
Gross Profit | 117,124 | 26.4 | 4,862 | 15.5 | 112,262 | |||||||||||||||
Operating expenses | ||||||||||||||||||||
General and administrative | 210,499 | 47.4 | 18,006 | 57.5 | 192,493 | |||||||||||||||
Selling and marketing | 94,305 | 21.3 | 21,445 | 68.5 | 72,860 | |||||||||||||||
Research and development | 30,372 | 6.8 | — | — | 30,372 | |||||||||||||||
Total operating expenses | 335,176 | 75.5 | 39,451 | 126.0 | 295,725 | |||||||||||||||
Income (loss) from operations | (218,052 | ) | (49.1 | ) | (34,589 | ) | (110.5 | ) | (183,463 | ) | ||||||||||
Other income (expense) | ||||||||||||||||||||
Interest income (expense), net | (8,786 | ) | (2.0 | ) | (43 | ) | (0.1 | ) | (8,743 | ) | ||||||||||
Total other income (expense) | (8,786 | ) | (2.0 | ) | (43 | ) | (0.1 | ) | (8,743 | ) | ||||||||||
Net income (loss) before income taxes | (226,838 | ) | (51.1 | ) | (34,632 | ) | (110.6 | ) | (192,206 | ) | ||||||||||
Income tax expense (benefit) | — | — | — | — | — | |||||||||||||||
Net income (loss) | $ | (226,838 | ) | (51.1 | ) | $ | (34,632 | ) | (110.6 | ) | $ | (192,206 | ) |
Revenues
Total revenues were $443,667 for the three months ended March 31, 2015, compared to $31,312 for the three months ended March 31, 2014, an increase of $412,355. This increase was primarily due to the further establishment of our products and equipment offerings and growth in our client base and volume of operations as our business has matured following commencement of business operations in April 2013. For the three months ended March 31, 2015, consulting services revenue was $195,570, or 44.1% of total revenue, compared to $23,864, or 76.2% of total revenues for the three months ended March 31, 2014. For the three months ended March 31, 2015, products and equipment revenue was $248,097, or 55.9% of total revenues, compared to $7,448, or 23.8% of total revenues for the three months ended March 31, 2014.
Costs of Revenues
Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the three months ended March 31, 2015, our total costs of revenues were $326,543, or 73.6% of total revenues. This compares to total costs of revenues for the three months ended March 31, 2014 of $26,450, or 84.5% of total revenues. The increase in costs of revenues of $300,093 was primarily due to the increase in sales volume discussed above and internal infrastructure development. For the three months ended March 31, 2015, consulting-related costs were $100,892, or 22.7% of total revenue, as compared to costs of $19,425, or 62.0% of revenue for the three months ended March 31, 2014. Costs associated with products and equipment were $225,651, or 50.9% of total revenue for the three months ended March 31, 2015 as compared to $7,025, or 22.4% of total revenue for the three months ended March 31, 2014. As a percentage of revenues, the decreases were primarily due to higher sales volume during the three months ended March 31, 2015, as certain primarily-fixed costs such as labor made up a comparably smaller percentage of revenues.
Gross Profit
Total gross profit was $117,124 for the three months ended March 31, 2015, comprised of consulting services gross profit of $94,678 and products and equipment gross profit of $22,446. This compares to total gross profit of $4,862 for the three months ended March 31, 2014, comprised of consulting services gross profit of $4,439 and products and equipment gross profit of $423. These increases of $90,239 for consulting services gross profit and $22,023 for products and equipment gross profit were primarily due to growth in our client base and volume of operations and further establishment of our products and equipment offerings. As a percentage of total revenues, gross profit was 26.4% for the three months ended March 31, 2015 and 15.5% for the three months ended March 31, 2014. This increase was primarily due to higher sales volume during the three months ended March 31, 2015.
Operating Expenses
Total operating expenses were $335,176, or 75.5% of total revenues for the three months ended March 31, 2015, compared to $39,451, or 126.0% of total revenues for the three months ended March 31, 2014. This increase was primarily due to increased headcount to meet the increasing demand and address selling, marketing and research and development functions, as well as higher operating expenses associated with becoming an SEC registrant. Professional fees, which include legal, auditing and accounting expenses, were $161,187 for the three months ended March 31, 2015, or 48.1% of total operating expenses for the period, compared to $6,080, or 15.4% of total operating expenses for the three months ended March 31, 2014.
Other Income (Expense)
Other income (expense) for the three months ended March 31, 2015 was expense of $8,786, which was comprised of non-cash interest expense of $8,803 on convertible notes payable discount amortization during the period, partially offset by $17 of interest income. Other income (expense) for the three months ended March 31, 2014 of $43 of expense was comprised of interest expense related to a short-term note payable we held during that period.
Income Tax Expense (Benefit)
Although our tax status changed from a non-taxable pass-through entity (S-Corporation) to a taxable entity (C-Corporation) during the year ended December 31, 2014, due to cumulative losses since we became a C-Corporation, we recorded a valuation allowance against our related deferred tax asset which netted our deferred tax asset and benefit for income taxes to zero for the three months ended March 31 2015. We were an S-Corporation throughout the three months ended March 31, 2014, and accordingly, no provision or benefit for income taxes was applicable.
Net Income (Loss)
As a result of the factors discussed above, net income (expense) for the three months ended March 31, 2015 was net loss of $226,838, or 51.1% of total revenues for the period, as compared to a net loss of $34,632, or 110.6% of total revenues for the three months ended March 31, 2014.
Liquidity and Capital Resources
As of March 31, 2015, our primary internal sources of liquidity was our working capital, which included cash and cash equivalents of $316,771 and accounts receivable of $106,185. We also have the ability to raise additional capital as needed through external equity financing transactions. For the three months ended March 31, 2015, primarily as a result of non-cash expenses, the Company’s operating cash flows were a use of $87,192 despite a net loss of $226,838. Additionally, considering that our fixed overhead costs are low, we have the ability to issue stock to compensate employees and management, and the level of future revenue we expect to generate from executed client contracts, we believe our liquidity and capital resources to be adequate to fund our operational and general and administrative expenses for at least the next 12 months without needing to raise additional debt or equity funding. There is no guarantee we will have the ability to raise additional capital as needed through external equity financing transactions if required.
Operating Activities
Net cash used in by operating activities for the three months ended March 31, 2015 was $87,192, consisting of net loss of $226,838, non-cash adjustments reconciling net income to net cash used in operating activities of $116,631 and a net source of cash of $23,015 from changes in operating assets and liabilities. The net non-cash adjustments of $116,631 were due to amortization of the discount on convertible notes payable of $8,803, employee stock-based compensation of $43,271, professional services compensated in shares of common stock of $63,841 and depreciation of $716. Changes in operating assets and liabilities, a net source of cash of $23,015, were the result of an increase in accounts payable of $182,026, a decrease in deposits of $116,929 due to receipt and sell-through of previously backlogged inventory and an increase in accrued and other current liabilities of $72,312, partially offset by a decrease in deferred revenue of $148,528, an increase in inventory of $146,225, an increase in accounts receivable of $48,542 and an increase in prepaid expenses and other current assets of $4,957.
For the three months ended March 31, 2014, net cash used in operating activities was $32,362, which consisted of net loss of $34,632, non-cash adjustments reconciling net income to net cash provided by operating activities of $147 (depreciation expense), and changes in operating assets and liabilities of $2,123. The change in operating assets and liabilities was the result of an increase of deposits of $27,000 being mostly offset by an increase in accrued liabilities and other current assets of $17,862, an increase in deferred revenue of $3,516, an increase in accounts payable of $3,377, a decrease in prepaid expenses and other current assets of $3,118 and a decrease in accounts receivable of $1,250.
Investing Activities
Investing activities were a use of cash of $11,250 for the three months ended March 31, 2015 due to additional spendiing on our demonstration inventory unit which is classified as construction-in-progress. There were no investing cash flows during the three months ended March 31, 2014.
Financing Activities
Net cash provided by financing activities of $250,000 for the three months ended March 31, 2015 reflected the sale of 833,333 shares of common stock to an investor during the period. During the three months ended March 31, 2014, financing activities were a use of $31,000, as $35,000 received from the issuance of short-term notes was partially offset by $4,000 in distributions to owners.
Off Balance Sheet Arrangements
As of March 31, 2015 and December 31, 2014, we did not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
Non-GAAP Financial Measures
We use Adjusted EBITA, a non-GAAP metric, to monitor our overall business performance. We define Adjusted EBITA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation and certain non-recurring expenses, which to date have been limited to costs associated with the Reverse Merger. We believe that such adjustments to arrive at Adjusted EBITA provides us with a more comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in the evaluation of our company.
A reconciliation of net income (loss) to Adjusted EBITA is provided below.
Three Months | Three Months | |||||||
Ended | Ended | |||||||
March 31, 2015 (Unaudited) | March 31, 2014 (Unaudited) | |||||||
Adjusted EBITA Reconciliation: | ||||||||
Net income (loss) | $ | (226,838 | ) | $ | (34,632 | ) | ||
Stock-based compensation to employees | 43,271 | — | ||||||
Stock-based compensation to service providers | 63,841 | — | ||||||
Interest expense, net | 8,786 | 43 | ||||||
Tax expense (benefit) | — | — | ||||||
Adjusted EBITA | $ | (110,940 | ) | $ | (34,589 | ) |
ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.
ITEM 4. CONTROLS AND PROCEDURES
Management of the Company is responsible for maintaining disclosure controls and procedures that are designed to ensure that financial information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the timeframes specified in the Securities and Exchange Commission’s rules and forms, consistent with Items 307 and 308 of Regulation S-K.
In addition, the disclosure controls and procedures must ensure that such financial information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.
As of March 31, 2015, an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) was carried out under the supervision and with the participation of our Chief Executive Officer, Chief Financial Officer, and other persons carrying out similar functions for the Company. Based on the evaluation of the Company’s disclosure controls and procedures, the Company concluded that during the period covered by this report, such disclosure controls and procedures were effective.
The Company continues to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, the Company evaluates and assesses its internal controls and procedures regarding its financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary and on an on-going basis.
Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of the prevention or detection of misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Changes in Internal Controls
The Company has no reportable changes to its internal controls over financial reporting for the period covered by this report.
The Company will continually enhance and test its internal controls over financial reporting on a continuing basis. Additionally, the Company’s management, under the control of its Chief Executive Officer and Chief Financial Officer, will increase its review of its disclosure controls and procedures on an ongoing basis. Finally, the Company plans to designate, in conjunction with its Chief Financial Officer, individuals responsible for identifying reportable developments and the process for resolving compliance issues related to them. The Company believes these actions will focus necessary attention and resources in its internal accounting functions.
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The Company is not currently a party to any pending legal proceedings.
ITEM 1A. RISK FACTORS
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
No transactions meeting the reporting requirements of this item occurred during the periods covered by this report.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
No senior securities were issued and outstanding during the three months ended March 31, 2015 or 2014.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS
This list is intended to constitute the exhibit index.
31.1 | Certification of Principal Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2 | Certification of Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1 | Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
32.2 | Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101.INS | XBRL Instance Document* |
101.SCH | XBRL Taxonomy Extension Schema Document* |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document* |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document* |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document* |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document* |
*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
American Cannabis Company, Inc. | ||||
Date: May 19, 2015 | By: | /s/ Corey Hollister | ||
Corey Hollister, | ||||
Chief Executive Officer | ||||
(Principal Executive Officer) |
Date: May 19, 2015 | By: | /s/ Antonio Migliarese | ||
Antonio Migliarese, | ||||
Chief Financial Officer | ||||
(Principal Financial Officer) |